• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

384 例 FIGO 2014 期 IB 宫颈癌患者的预后因素:肿瘤大小对预后的作用是什么?

The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?

机构信息

Gynecologic Oncology Department, Health Sciences University Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital , Ankara, Turkey.

Gynecology and Obstetrics Department, Health Sciences University Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital, Ankara, Turkey.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2021 Nov;266:126-132. doi: 10.1016/j.ejogrb.2021.09.028. Epub 2021 Sep 28.

DOI:10.1016/j.ejogrb.2021.09.028
PMID:34634671
Abstract

OBJECTIVE

To define the relationship of tumor size with surgico-pathological factors and oncological outcome in FIGO 2014 stage IB cervical cancer.

METHODS

This study retrospectively evaluated 384 FIGO 2014 Stage IB cervical cancer patients who underwent radical hysterectomy and lymphadenectomy. Tumor size was stratified according to 2 cm (≤ 2cm, 2-≤4 cm, >4 cm) and 4 cm (≤4 cm, >4 cm), and the relationship with poor prognostic factors, and the effects on survival were examined. The distribution of prognostic factors was compared between three subgroups: ≤2 cm vs. 2-≤4 cm; 2-≤4 cm vs. > 4 cm and ≤ 2 cm vs. > 4 cm. Survival rate was evaluated using the Kaplan-Meier method and compared with the log-rank test. Multivariate analysis was performed using Cox proportional-hazards regression.

RESULTS

Stratification of tumor size according to 4 cm was found to better determine pelvic lymph node determination. Parametrial involvement, uterine involvement and deep cervical stromal invasion were correlated with increasing tumor size. Lymph node involvement and uterine involvement were an independent prognostic risk factor for recurrence and cancer-specific survival. Tumor size showed no association with prognosis.

CONCLUSION

There is no meaningful cut-off value for tumor size determining all surgico-pathological factors. There was also seen to be no association between tumor size and recurrence or disease-related mortality.

摘要

目的

定义肿瘤大小与 FIGO 2014 分期 IB 宫颈癌的手术病理因素和肿瘤学结局的关系。

方法

本研究回顾性评估了 384 例接受根治性子宫切除术和淋巴结切除术的 FIGO 2014 分期 IB 宫颈癌患者。根据 2cm(≤2cm、2-≤4cm、>4cm)和 4cm(≤4cm、>4cm)将肿瘤大小分层,并检查与不良预后因素的关系及其对生存的影响。在≤2cm 与 2-≤4cm、2-≤4cm 与>4cm 以及≤2cm 与>4cm 这三个亚组之间比较了预后因素的分布。使用 Kaplan-Meier 方法评估生存率,并使用对数秩检验进行比较。使用 Cox 比例风险回归进行多变量分析。

结果

根据 4cm 对肿瘤大小进行分层,发现可以更好地确定盆腔淋巴结的情况。旁膜浸润、子宫浸润和宫颈深层间质浸润与肿瘤大小的增加相关。淋巴结浸润和子宫浸润是复发和癌症特异性生存的独立预后危险因素。肿瘤大小与预后无关。

结论

肿瘤大小没有确定所有手术病理因素的有意义的截止值。肿瘤大小与复发或疾病相关死亡率之间也没有关联。

相似文献

1
The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?384 例 FIGO 2014 期 IB 宫颈癌患者的预后因素:肿瘤大小对预后的作用是什么?
Eur J Obstet Gynecol Reprod Biol. 2021 Nov;266:126-132. doi: 10.1016/j.ejogrb.2021.09.028. Epub 2021 Sep 28.
2
[Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].[I a2-II a2期宫颈癌腹腔镜与开腹根治性子宫切除术后的长期肿瘤学结局:一项配对队列研究]
Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):894-901.
3
Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.接受根治性子宫切除术和系统性腹膜后淋巴结清扫术治疗的浸润性宫颈癌组织病理学预后因素的多变量分析。
Acta Obstet Gynecol Scand. 2002 Dec;81(12):1144-51. doi: 10.1034/j.1600-0412.2002.811208.x.
4
[Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].[Ib期和IIa期宫颈鳞状细胞癌患者的预后因素分析]
Zhonghua Fu Chan Ke Za Zhi. 2005 Apr;40(4):239-42.
5
Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.国际妇产科联盟(FIGO)IB期无淋巴结转移宫颈癌的预后因素及根治性子宫切除术后辅助放疗的作用
Int J Gynecol Cancer. 2004 Mar-Apr;14(2):286-92. doi: 10.1111/j.1048-891X.2004.014212.x.
6
The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.2018年国际妇产科联盟(FIGO)IB2期宫颈癌患者行根治性子宫切除术后的最佳肿瘤大小上限。
Int J Gynecol Cancer. 2020 Jul;30(7):975-980. doi: 10.1136/ijgc-2020-001271. Epub 2020 May 28.
7
Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.淋巴结阴性Ⅰ期-ⅡA 期宫颈癌根治性子宫切除术后无病生存预测的术后列线图。
J Obstet Gynaecol. 2020 Jul;40(5):699-704. doi: 10.1080/01443615.2019.1652888. Epub 2019 Oct 12.
8
A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer.肿瘤大小 2 cm 截断值对 FIGO 分期 IB 期宫颈癌手术治疗具有预后价值。
Gynecol Oncol. 2014 Jul;134(1):42-6. doi: 10.1016/j.ygyno.2014.04.011. Epub 2014 Apr 24.
9
Identifying selection criteria for non-radical hysterectomy in FIGO stage IB cervical cancer.确定国际妇产科联盟(FIGO)IB期宫颈癌非根治性子宫切除术的选择标准。
J Obstet Gynaecol Res. 2019 Apr;45(4):882-891. doi: 10.1111/jog.13902. Epub 2019 Jan 22.
10
Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.FIGO IIB期宫颈癌根治性子宫切除术:临床病理特征及预后评估
Gynecol Oncol. 2009 Jul;114(1):69-74. doi: 10.1016/j.ygyno.2009.03.026. Epub 2009 Apr 26.

引用本文的文献

1
Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy Combined with Intracavitary Posterior Radiotherapy for the Treatment of Medium-Term and Advanced Cervical Cancer: Efficacy, Safety and Prognostic Factors.调强放射治疗与三维适形放射治疗联合腔内后装放射治疗中晚期宫颈癌的疗效、安全性及预后因素
Front Surg. 2022 May 23;9:906117. doi: 10.3389/fsurg.2022.906117. eCollection 2022.